-+ 0.00%
-+ 0.00%
-+ 0.00%

Sana Biotechnology Q2 Adj. EPS $(0.13) Beats $(0.15) Estimate

Benzinga·08/10/2026 21:04:35
Listen to the news
Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.15) by 13.33 percent. This is a 18.75 percent increase over losses of $(0.16) per share from the same period last year.